IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

FINAZZI, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.162
NA - Nord America 1.093
AS - Asia 763
SA - Sud America 24
OC - Oceania 22
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.079
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 1.129
US - Stati Uniti d'America 1.055
IT - Italia 341
CN - Cina 245
GB - Regno Unito 211
JP - Giappone 191
SG - Singapore 100
IN - India 78
SE - Svezia 77
IE - Irlanda 67
FR - Francia 50
ES - Italia 41
RU - Federazione Russa 36
DK - Danimarca 28
CA - Canada 26
PL - Polonia 25
CH - Svizzera 24
FI - Finlandia 23
ID - Indonesia 22
TW - Taiwan 22
KR - Corea 20
NL - Olanda 20
AT - Austria 17
AU - Australia 15
VN - Vietnam 15
TR - Turchia 14
GR - Grecia 12
MX - Messico 12
SA - Arabia Saudita 11
TH - Thailandia 11
CO - Colombia 10
IL - Israele 10
RS - Serbia 10
UA - Ucraina 10
HR - Croazia 9
BE - Belgio 7
NZ - Nuova Zelanda 7
AR - Argentina 6
HK - Hong Kong 6
SI - Slovenia 6
BG - Bulgaria 5
PT - Portogallo 5
BR - Brasile 4
CZ - Repubblica Ceca 4
IR - Iran 4
RO - Romania 4
CL - Cile 3
SC - Seychelles 3
BN - Brunei Darussalam 2
GE - Georgia 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
QA - Qatar 2
UG - Uganda 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.080
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.010
Southend 162
Chandler 129
Milan 105
Fairfield 84
Singapore 69
Dublin 66
Ashburn 53
Princeton 52
Redwood City 51
Seattle 46
Beijing 45
Wilmington 45
Tokyo 40
Hanover 36
Houston 33
Woodbridge 33
New York 30
Tianjin 27
Cambridge 25
Bengaluru 24
Ann Arbor 23
Santa Clara 16
Des Moines 14
Dong Ket 14
Jakarta 14
Rome 14
Madrid 13
Rochester 13
Taipei 13
Fremont 12
Hyderabad 12
Krakow 12
Nanjing 12
Helsinki 11
Berlin 10
Bologna 10
Brooklyn 10
Guangzhou 10
Messina 10
Cattolica 9
Jeddah 9
Shanghai 9
Vienna 9
Barcelona 8
Bergamo 8
Boston 8
Chicago 8
Florence 8
San Diego 8
Sunnyvale 8
Bogotá 7
Hangzhou 7
Marugame 7
Reston 7
Seoul 7
Sydney 7
Toronto 7
Utrecht 7
Warsaw 7
Wuhan 7
Azzano San Paolo 6
Bangkok 6
Fiesole 6
Hebei 6
Montreal 6
Nishikichō 6
Potomac 6
Baltimore 5
Bordeaux 5
Brussels 5
Changsha 5
Christchurch 5
Dallas 5
Eitensheim 5
Kent 5
Naples 5
Napoli 5
Paris 5
Phoenix 5
Shenyang 5
Shinchiba 5
Utsunomiya 5
Amsterdam 4
Belgrade 4
Brescia 4
Bühl 4
Collegeville 4
Cuauhtémoc 4
Dearborn 4
Denver 4
Durham 4
Elâzığ 4
Funabashi 4
Haikou 4
Istanbul 4
Jiaxing 4
Kitamachi 4
Le Bouscat 4
Maebashi 4
Totale 2.755
Salva come PNG Salva come JPEG
Nome #
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera : a propensity-matched study 886
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms : an European Leukemia Net study 426
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis 171
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis 159
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 158
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia : a report from the MPN subcommittee of the chronic malignancies working party of the European group for blood and marrow transplantation 151
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 147
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts 139
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients 133
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis 133
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea 119
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis 116
Busulfan or thiotepa based conditioning in myelofibrosis: A phase II multicenter randomized study from the GITMO group 113
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 112
CALR mutation, MPL mutation and triple negativity identify patients with the lowest vascular risk in primary myelofibrosis 110
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 106
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms 96
Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival 91
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy 86
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 86
A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy 79
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT 76
Second primary malignancies in ruxolitinib-treated myelofibrosis : real-world evidence from 219 consecutive patients 71
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma 69
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 68
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer 62
Detection of driver and subclonal mutations in myelofibrosis : clinical impact on pharmacologic and transplant based treatment strategies 61
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 56
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 55
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 54
Front-line therapy in polycythemia vera and essential thrombocythemia 33
Totale 4.222
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 0 0 4 22 15 13 14 12 45 28 12 21
2020/2021564 23 39 35 60 55 64 59 58 37 35 43 56
2021/2022672 74 41 67 53 58 34 37 41 81 67 39 80
2022/2023678 57 51 64 58 64 100 22 60 92 22 53 35
2023/20241.378 38 63 47 57 118 49 187 180 97 152 204 186
2024/2025520 170 200 150 0 0 0 0 0 0 0 0 0
Totale 4.222